Research output per year
Research output per year
Personal profile
Headline
CLINICAL PROFESSOR
Fingerprint
Dive into the research topics where Howard Fillit is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Dynamic proportional loss of functional connectivity revealed change of left superior frontal gyrus in subjective cognitive decline: an explanatory study based on Chinese and Western cohorts
For the Alzheimer’s Disease Neuroimaging Initiative, 2025, (Accepted/In press) In: GeroScience.Research output: Contribution to journal › Article › peer-review
-
Implementing early detection of cognitive impairment in primary care to improve care for older adults
Fowler, N. R., Partrick, K. A., Taylor, J., Hornbecker, M., Kelleher, K., Boustani, M., Cummings, J. L., MacLeod, T., Mielke, M. M., Brosch, J. R., Lee, J., Shobin, E., Galvin, J. E., Fillit, H., Udeh-Momoh, C. & Willis, D. R., Jul 2025, In: Journal of Internal Medicine. 298, 1, p. 31-45 15 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
Key considerations for combination therapy in Alzheimer's clinical trials: Perspectives from an expert advisory board convened by the Alzheimer's drug discovery foundation
Cummings, J., Gold, M., Mintun, M., Irizarry, M., von Eschenbach, A., Hendrix, S., Berry, D., Sampaio, C., Sink, K., Landen, J., Kivipelto, M., Grundman, M., Arnold, S. E., Green, A., Partrick, K., Nisenbaum, L., Burstein, A. & Fillit, H., 1 Jan 2025, In: The journal of prevention of Alzheimer's disease. 12, 1, p. 100001 1 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Local molecular and connectomic contributions of tau-related neurodegeneration
for the Alzheimer’s disease Neuroimaging Initiative (ADNI), Feb 2025, In: GeroScience. 47, 1, p. 227-246 20 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Alzheimer’s Disease Linkage to Real-World Evidence (AD-LINE) Study: Linking Claims Data to Phase 3 GRADUATE Study of Gantenerumab
Fillit, H., Seleri Assunção, S., Majda, T., Ng, C. D., To, T. M., Abbass, I. M., Raimundo, K., Wallick, C. & Tcheremissine, O. V., Oct 2024, In: The journal of prevention of Alzheimer's disease. 11, 5, p. 1251-1259 9 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations
Press/Media
-
Weekly: Quanterix (QTRX: $4.85) increases 1.3% on average volume; +6c [1.3%]
24/05/25
1 item of Media coverage
Press/Media
-
Alzheimer's Drug Discovery Foundation Invests USD2.16 Million in Life Molecular Imaging
21/05/25
1 item of Media coverage
Press/Media
-
First-of-its-kind Alzheimer's blood test made by Malvern company gets FDA clearance
21/05/25
1 item of Media coverage
Press/Media
-
First FDA-cleared Alzheimer's blood test could make diagnoses faster, more accurate
21/05/25
119 items of Media coverage
Press/Media